|
Volumn 28, Issue 4, 2008, Pages 646-648
|
Anti-human IgG-dextran-adriamycin conjugate for immunotargeting of S180 sarcoma: effects on the tumor weight and survival time of the tumor-bearing mice
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI IGG;
ANTI-IGG;
ANTIIDIOTYPIC ANTIBODY;
ANTINEOPLASTIC AGENT;
DEXTRAN;
DOXORUBICIN;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN G DEXTRAN CONJUGATE;
IMMUNOGLOBULIN G-DEXTRAN CONJUGATE;
IMMUNOTOXIN;
MONOCLONAL ANTIBODY;
ANIMAL;
ARTICLE;
CELL SURVIVAL;
DRUG EFFECT;
FEMALE;
MOUSE;
PATHOLOGY;
SARCOMA 180;
SURVIVAL;
TUMOR VOLUME;
ANIMALS;
ANTIBODIES, ANTI-IDIOTYPIC;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CELL SURVIVAL;
DEXTRANS;
DOXORUBICIN;
FEMALE;
IMMUNOGLOBULIN G;
IMMUNOTOXINS;
MICE;
SARCOMA 180;
SURVIVAL ANALYSIS;
TUMOR BURDEN;
|
EID: 63149112149
PISSN: 16734254
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|